drugset / Trial / NCT05248048
NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer
Phase 0
Unknown
9 enrolled
The Third Affiliated Hospital of Guangzhou Medical University
Hangzhou Cheetah Cell Therapeutics Co., Ltd · collab
NaSequentialOpen-labelTreatment
Summary
Evaluate the clinical safety and feasibility of NKG2D CAR-T administrated by hepatic artery transfusion for patients with previously treated liver metastatic colorectal cancer.
Timeline
- Start
- 2021-09-13
- Primary completion
- 2022-10
- Completion
- 2022-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NKG2D CAR-NK | Cell therapy | — | Other |